ORIENT BIO Inc. (KRX:002630)
1,136.00
-17.00 (-1.47%)
Nov 20, 2026, 3:30 PM KST
ORIENT BIO Market Cap
ORIENT BIO has a market cap or net worth of 33.67 billion as of November 20, 2026. It is the 34,699th most valuable company in the world and the 2,013th biggest in South Korea. Its market cap has decreased by 50.95% in one year.
Market Cap
33.67B
Enterprise Value
n/a
Revenue
59.09B
Global Rank
Country Rank
#2,013 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since August 30, 1995, ORIENT BIO's market cap has increased from 31.20B to 33.67B, an increase of 7.93%. That is a compound annual growth rate of 0.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 33.67B | -52.75% |
| Dec 30, 2025 | 71.26B | -61.15% |
| Dec 30, 2024 | 183.42B | 154.86% |
| Dec 28, 2023 | 71.97B | -0.98% |
| Dec 29, 2022 | 72.68B | -49.75% |
| Dec 30, 2021 | 144.65B | -3.55% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MedPacto | 125.28B |
| HLB Therapeutics | 102.77B |
| Vaxcell-Bio Therapeutics | 81.75B |
| Genexine | 80.77B |
| iNtRON Biotechnology | 76.77B |
| Amicogen | 62.42B |
| GeneOne Life Science | 48.42B |
| Prestige BioPharma | 44.35B |